相关实验视频

Updated: Sep 18, 2025

Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease

Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease

Published on: May 9, 2022

激光疗法与安慰剂治疗胃口:一个系统的审查和元分析

Muhammad Imran Ullah¹, Muhammad Noman Khan², Umer Ullah³

¹Hayatabad Medical Complex, Peshawar, Pakistan.

Lasers in medical science

|June 25, 2025

概括

激光疗法有效地减少疼痛,加快胃口的愈合速度. 需要进一步的研究来规范激光治疗方案以获得最佳的结果.

科学领域:

口腔医学是指口腔医学.
激光治疗学激光治疗学
基于证据的牙科.

背景情况:

口腔是常见的,疼痛的口腔粘膜病变.
激光疗法显示出缓解疼痛和增强粘膜愈合的潜力.
需要对激光治疗对口腔的临床效益进行系统的评估.

研究的目的:

系统地评估激光疗法对口腔的疗效.
综合来自随机对照试验 (RCT) 关于减轻疼痛,愈合时间和大小的证据.
评估激光疗法作为口的辅助治疗的潜力.

主要方法:

在五个数据库中对2020-2025年间发表的RCT进行系统搜索.
提取和综合有关疼痛强度,愈合时间和大小的数据.
使用95%置信区间 (CI) 计算平均差异 (MDs).

主要成果:

分析了14个带有517名参与者的RCT.
与安慰剂相比,激光治疗显著降低了疼痛强度 (MD, 3.31) 和愈合时间 (MD, -5.86天) (p < 0.001).
没有观察到大小的显著变化 (MD, -0.87毫米;p = 0.52). 发现了相当大的异质性 (I2>89%).

结论:

激光疗法可显著减轻疼痛,并加速治疗口腔.
它显示作为辅助治疗模式的希望.
高异质性需要标准化协议和进一步高质量的研究来优化激光参数.

关键词:

胃口的病是什么意思皮质类固醇是一种皮质类固醇.炎症炎症是一种炎症.激光疗法是一种激光疗法.口腔粘膜中的口腔粘膜.疼痛疼痛疼痛疼痛

更多相关视频

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

Published on: May 23, 2025

Method for the Assessment of Effects of a Range of Wavelengths and Intensities of Red/near-infrared Light Therapy on Oxidative Stress In Vitro

Method for the Assessment of Effects of a Range of Wavelengths and Intensities of Red/near-infrared Light Therapy on Oxidative Stress In Vitro

Published on: March 21, 2015

相关概念视频

Peptic Ulcer Disease IV: Management

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...